These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 6613079)

  • 21. A sero-epidemiological cross-sectional study of hepatitis B virus in Zimbabwe.
    Tswana S; Chetsanga C; Nyström L; Moyo S; Nzara M; Chieza L
    S Afr Med J; 1996 Jan; 86(1):72-5. PubMed ID: 8685787
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The prevalence of hepatitis B surface antigen (HBsAg), anti-hepatitis B surface (anti-HBs) and anti-hepatitis B core (anti-HBc) in patients with acquired immuno-deficiency syndrome (AIDS).
    Ogutu EO; Amayo EO; Okoth F; Lule GN
    East Afr Med J; 1990 May; 67(5):355-8. PubMed ID: 2390958
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Occult Hepatitis B Virus Infection in Nigerian Blood Donors and Hepatitis B Virus Transmission Risks.
    Oluyinka OO; Tong HV; Bui Tien S; Fagbami AH; Adekanle O; Ojurongbe O; Bock CT; Kremsner PG; Velavan TP
    PLoS One; 2015; 10(7):e0131912. PubMed ID: 26148052
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnostic significance of anti-HBcIgM prevalence related to symptoms in Canadian patients acutely or chronically infected with hepatitis B virus.
    Chernesky M; Mahony J; Castriciano S; Sekla L; Bishai F; Vas S
    J Med Virol; 1986 Nov; 20(3):269-77. PubMed ID: 3537207
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Viral markers of hepatitis A and B: main characteristics and clinical significance].
    Lyra LG
    Arq Gastroenterol; 1983; 20(3):117-22. PubMed ID: 6329145
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatitis Be antigen and antibody in hepatitis B surface antigen positive blood donors.
    Barr A; Black SH; Burrell CJ; Dow B; Macvarish I
    J Clin Pathol; 1979 Feb; 32(2):132-5. PubMed ID: 108319
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Seven-year follow-up studies on asymptomatic HBs Ag carriers].
    Nishida S; Tada R; Nishiwaki T; Takahashi R; Yanagawa S; Mitamura K
    Sangyo Igaku; 1982 May; 24(3):253-64. PubMed ID: 7143797
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Age-specific prevalence of hepatitis B e antigen (HBeAg) and antibody to HBeAg (anti-HBe) among asymptomatic hepatitis B surface antigen (HBsAg) carriers in Okinawa and Kyushu, Japan.
    Kashiwagi S; Hayashi J; Nomura H; Kajiyama W; Ikematsu H; Shingu T; Hayashida K; Kaji M
    Microbiol Immunol; 1986; 30(7):675-82. PubMed ID: 3773791
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Markers of hepatitis B virus infection in infants born of mothers who are HBs-antigen carriers with anti-HBe present and the problems of passive immunoprophylaxis].
    Kuzin SN; Shakhgil'dian IV; Farber NA; Mikhaĭlov MI; Vorozhbieva TE
    Vopr Virusol; 1987; 32(1):59-63. PubMed ID: 3577108
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatitis B viral markers in surface antigen negative blood donors: the need to look beyond antibody negativity.
    Salawu L; Adegoke AO; Aboderin AO; Huraina HA
    West Afr J Med; 2011; 30(4):292-5. PubMed ID: 22669836
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Natural seroconversion from hepatitis Be antigen to antibody among hepatitis B virus carriers in Okinawa Islands.
    Sakugawa H; Ohwan T; Yamashiro A; Oyakawa T; Kadena K; Kinjo F; Saito A
    J Med Virol; 1991 Jun; 34(2):122-6. PubMed ID: 1890412
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HBsAg/IgM complexes as a prognostic marker of chronicity in acute hepatitis B virus infection.
    Ljunggren K; Hansson BG; Nordenfelt E
    Scand J Infect Dis; 1991; 23(5):529-34. PubMed ID: 1767250
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatitis B e antigen and antibody activity in hepatitis B virus infection.
    Tiku ML; Makhdoomi GM; Beutner KR; Nath N; Ogra PL
    J Pediatr; 1977 Oct; 91(4):540-4. PubMed ID: 908972
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HBe-Antigen in the course and prognosis of hepatitis B infection: a prospective study.
    Schulman AN; Fagen ND; Brezina M; Silver H; Nitzze A; Morton D; Gitnick GL
    Gastroenterology; 1980 Feb; 78(2):253-8. PubMed ID: 7350048
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatitis B virus and primary hepatocellular carcinoma: family studies in Korea.
    Hann HW; Kim CY; London WT; Whitford P; Blumberg BS
    Int J Cancer; 1982 Jul; 30(1):47-51. PubMed ID: 6288579
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Significance of tests for HBeAg and anti-HBe in HBsAg positive blood donors.
    Dow BC; Macvarish I; Barr A; Crawford RJ; Mitchell R
    J Clin Pathol; 1980 Nov; 33(11):1106-9. PubMed ID: 7440758
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatitis B virus strains from Rwandan blood donors are genetically similar and form one clade within subgenotype A1.
    Twagirumugabe T; Swaibu G; Walker TD; Lindh M; Gahutu JB; Bergström T; Norder H
    BMC Infect Dis; 2017 Jan; 17(1):32. PubMed ID: 28056881
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatitis B e antigen, DNA polymerase activity, and infection of household contacts with hepatitis B virus.
    Perrillo RP; Gelb L; Campbell C; Wellinghoff W; Ellis FR; Overby L; Aach RD
    Gastroenterology; 1979 Jun; 76(6):1319-25. PubMed ID: 437428
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of HBe antigen in sera from HBs antigen asymptomatic carrier and hepatitis patients using polyethylene glycol (PEG).
    Tsuji T; Okada T; Nagashima H
    Gastroenterol Jpn; 1979; 14(3):206-10. PubMed ID: 109343
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The reliability of personal and family medical histories in the identification of hepatitis B carriers.
    Comfort MB; Wu PC
    Oral Surg Oral Med Oral Pathol; 1989 May; 67(5):531-4. PubMed ID: 2717151
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.